metronidazole has been researched along with warfarin in 35 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (17.14) | 18.7374 |
1990's | 1 (2.86) | 18.2507 |
2000's | 9 (25.71) | 29.6817 |
2010's | 18 (51.43) | 24.3611 |
2020's | 1 (2.86) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Bloomer, WD; Papadopoulou, MV; Rosenzweig, HS | 1 |
Bajusz, D; Balogh, GT; Dargó, G; Müller, J; Simon, K | 1 |
Oakley, GP | 1 |
Gugler, R | 1 |
O'Reilly, RA | 1 |
Kazmier, FJ | 1 |
Lai, CM; Levy, G; Yacobi, A | 1 |
Mohr, K | 1 |
Bacques, O; Kiselman, R; Kleinknecht, D; Kolko, A; Russ, G | 1 |
Al Khadrawy, FM; Ramadan, NI | 1 |
Ditmer, D; Feldstein, AC; Krall, M; Perrin, N; Platt, R; Simon, SR; Sittig, DF; Smith, DH; Soumerai, SB; Yang, X | 1 |
Cao, YG; Chen, YC; Hao, K; Liu, XQ; Wang, GJ | 1 |
Arnold, LB; Finch, CK; Howard-Thompson, A; Hurdle, AC; Sands, C; Self, TH | 1 |
Bizzarri, B; Bolasco, A; Carradori, S; Chimenti, F; Chimenti, P; Granese, A; Rivanera, D; Scaltrito, MM; Secci, D; Sisto, F; Zicari, A | 1 |
Anderson, EA; Cantrell, MA; Egge, JA; Holt, RK; Shaw, RF | 1 |
Bonneau, A; Maresca, A; Supuran, CT; Winum, JY | 1 |
Hasegawa, S; Iida, J; Ike, H; Ito, K; Kagaya, H; Kudo, T; Sato, T; Shimada, K; Yamagishi, S; Yatsuno, Y | 1 |
Hersh, EV; Moore, PA | 1 |
Adlan, T; He, J; Lam, JC | 1 |
Aebischer, B; Akboga, MK; Akdamar, G; Alcalay, RN; Álvarez-Pérez, S; Aydogdu, S; Balci, KG; Barcaro, G; Bišová, K; Blanco, JL; Brewer, SH; Caruthers, SD; Ceylan, O; Chadwick, JA; Chang, DD; Che, JM; Chen, QQ; Chen, W; Chen, Z; Chung, M; Chung, W; Colecraft, HM; Coteli, E; Dogan, H; Dong, S; Elsig, S; Fahn, S; Fang, XJ; Feng, MG; Fenlon, EE; Floyd, KT; Fokdal, L; Ford, B; Fortunelli, A; Freudenberg, R; Gan-Or, Z; García, ME; Gillham, C; Giovannelli, D; Goertz, RS; Gulati, V; Haie-Meder, C; Hao, YY; Hatano, K; Hines, KJ; Hines, SM; Hirakawa, H; Hoskin, P; Hu, JH; Huang, P; Huang, Y; Hubicka, U; Inoue, Y; Ishii, N; Janssen, PM; Jin, Z; Johnson, A; Jürgenliemk-Schultz, I; Kaineder, K; Kamei, K; Kang, U; Karatas, F; Kash, TL; Katayama, Y; Keupp, J; Kirisits, C; Kisacik, H; Kodama, K; Kotzerke, J; Kryczyk, A; Kuhness, D; Kuo, S; Lanza, GM; Le Bris, N; Levin, DE; Levy, OA; Li, B; Li, H; Li, X; Liang, GD; Liang, Y; Liao, RQ; Lin, JT; Lindegaard, JC; Liong, C; Liu, B; Liu, C; Liu, GH; Liu, L; Liu, Q; Liu, X; Lowe, J; Lowery-Gionta, EG; Ma, YH; Maden, O; Mankad, V; Marder, KS; Marshall, SA; Martínez-Nevado, E; Maucksch, U; Mazeron, R; Mazzone, CM; Mazzoni, P; Mezricky, D; Mizokami, Y; Naumann, A; Navarro, M; Netzer, FP; Neurath, MF; Nie, Q; Oliva, P; Ozeke, O; Peláez, T; Pfeifer, L; Pleil, KE; Pomp, S; Pötter, R; Puckerin, AA; Rafael-Fortney, JA; Raman, SV; Rastogi, N; Řezanka, M; Řezanka, T; Rinker, JA; Rouleau, GA; Runge, R; Sahin, MD; Sakai, A; Schmieder, AH; Schmitz, AJ; Schultz, EJ; Šegedin, B; Sementa, L; Shen, Y; Shiotsuki, I; Shirahama, M; Staley, J; Starovoytov, V; Sterrer, M; Strobel, D; Sturdza, A; Subramanyam, P; Surnev, S; Swager, SA; Taeymans, J; Tan, H; Tan, LT; Tanderup, K; Temizhan, A; Terao, T; Thiele, TE; Tran, T; Tucker, MJ; Vetriani, C; Vítová, M; Wang, JP; Wang, L; Wang, M; Wang, X; Waters, CH; Weng, SX; Wickline, SA; Wildner, D; Wodarcyk, AJ; Wolf, P; Wu, L; Wu, YL; Wunderlich, G; Xiong, L; Xu, P; Yang, GS; Yang, XN; Yang, Y; Yayla, C; Ying, SH; Zachleder, V; Zhang, XG; Zhang, XK; Zhang, Y; Zheng, JY; Zhong, WZ; Zhu, J; Zhu, YJ; Żmudzki, P | 1 |
Ahmed, M; Aurangzeb, M; Yousaf, A | 1 |
Fioravanti, N; Loesch, EB; Lucius, D; Powers, A; Weiland, A | 1 |
4 review(s) available for metronidazole and warfarin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Drug influences on malformations.
Topics: Abnormalities, Drug-Induced; Amphetamines; Anesthetics; Animals; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Clomiphene; Female; Humans; Infant; Infant, Newborn; Lithium; Metronidazole; Pregnancy; Teratogens; Trimethadione; Warfarin | 1979 |
Three Serious Drug Interactions that Every Dentist Should Know About.
Topics: Adrenergic beta-Antagonists; Anti-Inflammatory Agents, Non-Steroidal; Bradycardia; Cytochrome P-450 CYP2C9; Dental Care; Drug Interactions; Epinephrine; Fluconazole; Hemorrhage; Humans; International Normalized Ratio; Lithium; Metronidazole; Propranolol; Warfarin | 2015 |
Topics: AC133 Antigen; Acenaphthenes; Acer; Acrosome Reaction; Adult; Agaricales; Aged; Aged, 80 and over; Animals; Animals, Zoo; Anti-Bacterial Agents; Anticoagulants; Antifungal Agents; Antimanic Agents; Antioxidants; Aortic Valve; Area Under Curve; ATP Binding Cassette Transporter, Subfamily G, Member 2; Bacillus; Bacterial Toxins; Bacterial Typing Techniques; Base Composition; Beauveria; Binge Drinking; Biomarkers; Bipolar Disorder; Blood Coagulation; Blotting, Western; Brachytherapy; Calcium Channels, L-Type; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Wall; Cells, Cultured; Ceramics; Chi-Square Distribution; China; Chlorophyll; Chlorophyta; Chloroplasts; Cholesterol, HDL; Chromatography, High Pressure Liquid; Chromobacterium; Clostridium perfringens; Clozapine; Constriction, Pathologic; Coronary Artery Bypass; Corticotropin-Releasing Hormone; Cross-Sectional Studies; Cytochrome P-450 CYP2C9; Dental Porcelain; Dental Restoration Failure; Dental Stress Analysis; Designer Drugs; Diaminopimelic Acid; DNA Fingerprinting; DNA, Bacterial; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Dosage Calculations; Drug Evaluation, Preclinical; Drug Resistance, Bacterial; Elasticity Imaging Techniques; Epsilonproteobacteria; Equipment Design; Ericaceae; Excitatory Amino Acid Antagonists; False Negative Reactions; Fatty Acids; Female; Food Analysis; Fresh Water; Gene Expression Regulation, Neoplastic; Glutathione; Graft Occlusion, Vascular; Heart Valve Prosthesis Implantation; Heart Ventricles; HEK293 Cells; Hemolymph; Humans; Hyaluronan Receptors; Hydrogen Peroxide; Hydrothermal Vents; Indoles; Inflammation Mediators; Inhibitory Concentration 50; Insecta; International Normalized Ratio; Isotope Labeling; Itraconazole; Kidney; Kinetics; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lamotrigine; Lanthanoid Series Elements; Limit of Detection; Linear Models; Lipid Peroxidation; Liver; Liver Cirrhosis; Logistic Models; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Malondialdehyde; Mediastinum; Metronidazole; Mice; Mice, Nude; Mice, Transgenic; Microbial Sensitivity Tests; Microscopy, Fluorescence; Middle Aged; Monocytes; Monomeric GTP-Binding Proteins; Multivariate Analysis; Myocytes, Cardiac; Neoplasm Staging; Neoplastic Stem Cells; Neural Pathways; Nitrates; Nucleic Acid Hybridization; Octamer Transcription Factor-3; Odds Ratio; Oxidation-Reduction; Oxidative Stress; Peptidoglycan; Phantoms, Imaging; Pharmacogenetics; Pharmacogenomic Variants; Phenotype; Phospholipids; Photolysis; Photosynthesis; Phylogeny; Plant Extracts; Polychaeta; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Preoperative Care; Prostatic Neoplasms; Pseudomonas aeruginosa; Pyrimidines; Pyrroles; Quorum Sensing; Radiology, Interventional; Radiopharmaceuticals; Radiotherapy Dosage; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; Reference Values; Regression Analysis; Retrospective Studies; Reverse Transcriptase Polymerase Chain Reaction; Rhizosphere; Risk Factors; RNA, Ribosomal, 16S; ROC Curve; Rutin; Saphenous Vein; Seawater; Selenium; Semen Preservation; Sensitivity and Specificity; Septal Nuclei; Sequence Analysis, DNA; Serum Albumin; Serum Albumin, Human; Shear Strength; Sodium Pertechnetate Tc 99m; Sodium-Hydrogen Exchangers; Soil Microbiology; SOXB1 Transcription Factors; Spain; Species Specificity; Sperm Motility; Spermatozoa; Spheroids, Cellular; Spores, Fungal; Stroke; Superoxide Dismutase; Swine; Tandem Mass Spectrometry; Technetium Compounds; Technetium Tc 99m Exametazime; Technetium Tc 99m Sestamibi; Temperature; Thiosulfates; Thrombosis; Thyroid Neoplasms; Transducers; Transfection; Transplantation, Heterologous; Treatment Outcome; Triazines; Tumor Burden; Urocortins; Uterine Cervical Neoplasms; Vacuoles; Valproic Acid; Ventral Tegmental Area; Vitamin K 2; Vitamin K Epoxide Reductases; Warfarin; Water Microbiology; Young Adult | 2016 |
1 trial(s) available for metronidazole and warfarin
Article | Year |
---|---|
Reducing warfarin medication interactions: an interrupted time series evaluation.
Topics: Acetaminophen; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Drug Interactions; Drug Prescriptions; Education, Medical, Continuing; Female; Fluconazole; Health Maintenance Organizations; Humans; Male; Medical Records Systems, Computerized; Metronidazole; Middle Aged; Sulfamethoxazole; Warfarin | 2006 |
30 other study(ies) available for metronidazole and warfarin
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
The antitubercular activity of various nitro(triazole/imidazole)-based compounds.
Topics: Animals; Antitubercular Agents; Cell Line; Chlorocebus aethiops; Dose-Response Relationship, Drug; Humans; Imidazoles; Macrophages; Mice; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nitro Compounds; Structure-Activity Relationship; Triazoles | 2017 |
Human Serum Albumin Binding in a Vial: A Novel UV-pH Titration Method To Assist Drug Design.
Topics: Binding Sites; Chemistry, Pharmaceutical; Drug Design; Humans; Hydrogen-Ion Concentration; Molecular Docking Simulation; Pharmaceutical Preparations; Protein Binding; Serum Albumin, Human; Spectrophotometry, Ultraviolet; Titrimetry | 2020 |
[Drug interactions in therapy using coumarin derivatives].
Topics: Allopurinol; Anti-Inflammatory Agents; Barbiturates; Biological Availability; Cholestyramine Resin; Coumarins; Drug Interactions; Humans; Metronidazole; Phenylbutazone; Rifampin; Sulfonamides; Tolbutamide | 1979 |
The stereoselective interaction of warfarin and metronidazole in man.
Topics: Adult; Blood Coagulation; Drug Synergism; Humans; Male; Metronidazole; Prothrombin Time; Stereoisomerism; Warfarin | 1976 |
A significant interaction between metronidazole and warfarin.
Topics: Adult; Drug Interactions; Female; Hemorrhage; Humans; Metronidazole; Warfarin | 1976 |
Pharmacokinetic and pharmacodynamic studies of acute interaction between warfarin enantiomers and metronidazole in rats.
Topics: Animals; Blood Proteins; Drug Interactions; In Vitro Techniques; Kinetics; Male; Metronidazole; Protein Binding; Prothrombin; Rats; Rats, Inbred Strains; Stereoisomerism; Warfarin | 1984 |
[Stereoselectivity of the warfarin effect].
Topics: Drug Synergism; Humans; Metronidazole; Warfarin | 1984 |
Acute renal failure due to bilateral ureteral hematomas complicating anticoagulant therapy.
Topics: Acute Kidney Injury; Aged; Female; Hematoma; Hemorrhage; Humans; Metronidazole; Ureteral Diseases; Warfarin | 1993 |
The in vitro effect of Assafoetida on Trichomonas vaginalis.
Topics: Animals; Antiprotozoal Agents; Coumarins; Female; Ferula; Humans; Metronidazole; Phytotherapy; Plant Oils; Sesquiterpenes; Trichomonas vaginalis | 2003 |
Warfarin maintenance dose adjustment with indirect pharmacodynamic model in rats.
Topics: Administration, Oral; Algorithms; Animals; Anticoagulants; Area Under Curve; Dose-Response Relationship, Drug; Enzyme Inhibitors; International Normalized Ratio; Male; Metronidazole; Models, Biological; Prothrombin Time; Rats; Rats, Sprague-Dawley; Time Factors; Warfarin | 2007 |
Intracerebral hemorrhage secondary to a warfarin-metronidazole interaction.
Topics: Aged; Anti-Infective Agents; Anticoagulants; Cerebral Hemorrhage; Drug Interactions; Female; Humans; International Normalized Ratio; Metronidazole; Warfarin | 2008 |
Synthesis, selective anti-Helicobacter pylori activity, and cytotoxicity of novel N-substituted-2-oxo-2H-1-benzopyran-3-carboxamides.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Cell Line; Coumarins; Drug Resistance, Bacterial; Helicobacter pylori; Humans; Interleukin-8; Metronidazole; Microbial Sensitivity Tests; Structure-Activity Relationship | 2010 |
Preemptive dose reduction of warfarin in patients initiating metronidazole.
Topics: Adult; Aged; Anti-Infective Agents; Anticoagulants; Blood Coagulation Tests; Drug Interactions; Endpoint Determination; Female; Humans; Male; Metronidazole; Middle Aged; Retrospective Studies; Warfarin; Young Adult | 2010 |
Warfarin.
Topics: Anti-Infective Agents; Anti-Ulcer Agents; Anticoagulants; Drug Interactions; Educational Measurement; Humans; Metronidazole; Omeprazole; Warfarin | 2011 |
Metronidazole-coumarin conjugates and 3-cyano-7-hydroxy-coumarin act as isoform-selective carbonic anhydrase inhibitors.
Topics: Biocatalysis; Carbon Dioxide; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Coumarins; Dose-Response Relationship, Drug; Enzyme Activation; Humans; Metronidazole; Molecular Structure; Protein Isoforms; Structure-Activity Relationship | 2013 |
Investigation of the safety of topical metronidazole from a pharmacokinetic perspective.
Topics: Administration, Topical; Animals; Anti-Infective Agents; Anticoagulants; Breast Neoplasms; Carcinoma, Ductal, Breast; Cytochrome P-450 Enzyme System; Drug Interactions; Female; Humans; Liver; Male; Metronidazole; Microsomes, Liver; Middle Aged; Odorants; Ointments; Rats; Rats, Sprague-Dawley; RNA, Messenger; Warfarin | 2013 |
Clival osteomyelitis and hypoglossal nerve palsy--rare complications of Lemierre's syndrome.
Topics: Adolescent; Anti-Infective Agents; Anticoagulants; Cranial Fossa, Posterior; Fever; Fusobacterium Infections; Fusobacterium necrophorum; Humans; Hypoglossal Nerve Diseases; Jugular Veins; Lemierre Syndrome; Male; Meropenem; Metronidazole; Osteomyelitis; Pharyngitis; Sepsis; Thienamycins; Treatment Outcome; Warfarin | 2015 |
Acute Appendicitis Complicating into Portal and Superior Mesenteric Vein Thrombosis.
Topics: Acute Disease; Adult; Anti-Infective Agents; Anticoagulants; Appendicitis; Humans; Male; Mesenteric Veins; Metronidazole; Portal Vein; Tomography, X-Ray Computed; Treatment Outcome; Venous Thrombosis; Warfarin | 2016 |
Preemptive warfarin dose reduction after initiation of sulfamethoxazole-trimethoprim or metronidazole.
Topics: Adult; Aged; Aged, 80 and over; Female; Hemorrhage; Humans; International Normalized Ratio; Male; Metronidazole; Middle Aged; Retrospective Studies; Thromboembolism; Trimethoprim, Sulfamethoxazole Drug Combination; Warfarin | 2017 |